• Profile

Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach

PLoS Medicine Apr 05, 2019

In this study, researchers quantified data to study the safety and efficacy of prophylactic human papillomavirus (HPV) immunization for males who have had sex with males (MSM). They noted a decline in the incidence of anogenital HPV infections with targeted vaccination to about 30% after 40 years, with a range of 10% to 50%, based on the recruitment of MSM into targeted campaigns and on the assumed mode of vaccine protection. They noted a further increase to 75% after 60 years when targeted vaccination was combined with sex-neutral vaccination in preadolescence, conferring uptake of 40% among 12-year-old boys and 85% effectiveness against future HPV16 infections in MSM. Overall, findings supported targeted vaccination to protect adult MSM, at least temporarily, at high risk for anal cancer.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen